New data from the federal Centers for Disease Control and Prevention show that new HIV infections fell by 8% between 2015 and 2019, largely thanks to a decline among young gay and bisexual men.
New data from the federal Centers for Disease Control and Prevention show that new HIV infections fell by 8% between 2015 and 2019, largely thanks to a decline among young gay and bisexual men.
BAAITS, a volunteer-based organization, established the first and largest public two-spirit powwow in the world.
This year s events take place February 2-6, culminating with the Grand Entry on the last day from noon to 4 p.m. Pacific Time.
A powwow is a traditional Native American event that gathers all tribes, as well as invites non-Native guests to learn more about Native cultures. Last year, the event welcomed more than 5,000 people at Fort Mason Center in San Francisco. Because of COVID-19 restrictions, BAAITS will hold the powwow online this year, according to a news release. It will include daily panels and workshops.
The federal Food and Drug Administration has approved Cabenuva, the first complete long-acting injectable HIV regimen that does not require daily pills. It is approved for people with an undetectable viral load who wish to switch to a long-acting regimen.
Cabenuva consists of extended-release versions of the new integrase inhibitor cabotegravir and rilpivirine (sold in pill form as Edurant). The two injections are administered in the buttocks once monthly by a health care provider. ViiV Healthcare expects to start shipping Cabenuva in February. The combination regimen will cost about $4,000 a month.
The FDA action took place January 21. Many of our clients, some of whom have been taking antiretrovirals daily for decades, have expressed interest in long-acting injectables, Janessa Broussard, R.N., vice president of medical affairs at the San Francisco AIDS Foundation, told the Bay Area Reporter. Adherence to a daily medication regimen can be difficult to maintain for a variety o